8-144513059-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004260.4(RECQL4):c.2543G>A(p.Arg848His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,579,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R848R) has been classified as Likely benign.
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.2543G>A | p.Arg848His | missense_variant | 15/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2543G>A | p.Arg848His | missense_variant | 15/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.1472G>A | p.Arg491His | missense_variant | 14/20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.713G>A | p.Arg238His | missense_variant | 6/8 | 5 | ENSP00000477457.1 | |||
ENSG00000265393 | ENST00000580385.1 | n.271+222C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152244Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000116 AC: 23AN: 197428Hom.: 0 AF XY: 0.0000931 AC XY: 10AN XY: 107390
GnomAD4 exome AF: 0.0000680 AC: 97AN: 1427342Hom.: 0 Cov.: 66 AF XY: 0.0000608 AC XY: 43AN XY: 706898
GnomAD4 genome AF: 0.000453 AC: 69AN: 152360Hom.: 0 Cov.: 34 AF XY: 0.000430 AC XY: 32AN XY: 74504
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 13, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | RECQL4: PM2, BP4 - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 29, 2022 | DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.2543G>A, in exon 15 that results in an amino acid change, p.Arg848His. This sequence change does not appear to have been previously described in individuals with RECQL4-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.15% in the African American subpopulation (dbSNP rs368989729). The p.Arg848His change affects a poorly conserved amino acid residue located in a domain of the RECQL4 protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD) provide contradictory results for the p.Arg848His substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Arg848His change remains unknown at this time. - |
Rothmund-Thomson syndrome;C0265308:Baller-Gerold syndrome;C1849453:Rapadilino syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Rothmund-Thomson syndrome type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 04, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Jul 30, 2021 | - - |
RECQL4-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 01, 2024 | The RECQL4 c.2543G>A variant is predicted to result in the amino acid substitution p.Arg848His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.15% of alleles in individuals of African descent in gnomAD. It has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from uncertain significance to likely benign; however, the majority of ClinVar submitters favor uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/459412/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Baller-Gerold syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at